3087 The NK-1 antagonist aprepitant (APR) in combination with granisetron and dexamethasone in high dose chemotherapy (HDC)

Autor: Mueller, F., Jordan, K., Jahn, P., Behlendorf, T., Sippel, C., Kegel, T., Wolf, H.H., Schmoll, H.J.
Zdroj: In EJC Supplements 2009 7(2):200-201
Databáze: ScienceDirect